Biktarvy 50-200-25 MG tablet UU 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F7PAD
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $30,677
Award facts
- Contract value 100% obligated
- $30,677.36 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $30.7K firm fixed-price delivery order to AmerisourceBergen Drug Corp on January 26, 2026, for the supply of BIKTARVY 50-200-25 mg tablets (30-count units). This is a non-set-aside contract with an ultimate completion date of January 27, 2026, with performance taking place at the contractor's facility in Conshohocken, Pennsylvania. BIKTARVY is an antiretroviral medication used in the treatment of HIV infection, representing the type of specialized pharmaceutical commodity essential to military and federal healthcare systems.
This delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999.99M and extending through December 2031. That master IDC serves as the comprehensive pharmaceutical supply vehicle for military treatment facilities and federal healthcare programs globally, covering an extensive range of brand-name and generic medications, vaccines, and medical supplies across multiple therapeutic domains. AmerisourceBergen's competitive award history and established position as a critical pharmaceutical distributor for federal medical procurement reflect its capability to efficiently fulfill government requirements for essential medical commodities.
Quick answers
Who was awarded contract SPE2DR26F7PAD?
SPE2DR26F7PAD was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 26, 2026.
How much is contract SPE2DR26F7PAD worth?
The government has obligated $30,677 on SPE2DR26F7PAD.
Is contract SPE2DR26F7PAD an order under another contract?
Yes. SPE2DR26F7PAD is a delivery order under SPE2DR25D7059, an indefinite delivery contract.
Was contract SPE2DR26F7PAD competed?
The extent of competition for SPE2DR26F7PAD was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award